Loading...
This chart shows how this clinic compares to all others nationwide for patients with your profile.
Explore the success rates, loss funnels, and patient volume data of a clinic. The success rates here should not be thought of as predictive for your Fertility Profile and are not generally useful for comparing clinics. For personalized success rates or to compare clinics, check the section above, or consult with a specialist.
This chart shows the clinic's success rates over time. Success is defined as the percentage of births associated with a procedure.
This diagram traces the journey of patient cycles through each stage of the fertility treatment process at this clinic within your age range. The width of each flow represents the percentage of patients reaching that stage.
This section shows trends in the number of cycles of patients treated at this clinic with characteristics similar to your profile over time.
This section shows the breakdown of patients treated at this clinic by age, donor status, and treatment approach in 2021.
This chart shows the most recent success rates for this clinic in 2021. Success is defined as the percentage of births associated with a procedure.
Founding Partner; Practice and Medical Director for RMA of New Jersey, RMA Network’s flagship fertility clinic. Board-certified in Reproductive Endocrinology, Obstetrician Gynecology and serves as REI Clinical Associate Professor at Rutgers-RWJ Medical School
Founding Partner; Practice and Medical Director for RMA of New Jersey, RMA Network’s flagship fertility clinic. Board-certified in Reproductive Endocrinology, Obstetrician Gynecology and serves as REI Clinical Associate Professor at Rutgers-RWJ Medical School
James R. Broussard Ph. D. HCLD (ABB). Dr. Broussard is board certified as a High Complexity Laboratory Director (HCLD) in embryology, He performed his graduate studies at Louisiana State University, obtaining a Masters (1992) and Ph. D. (1996) degree while majoring in reproductive physiology of the female. Dr. Broussard is a member of the American Society of Reproductive Medicine, Gamma Sigma Delta and the American Board of Bioanalysts.
| Birth Type | Intended | Actual | Transfers |
|---|---|---|---|
| Total live births | N/A | N/A | N/A |
| Singleton births | N/A | N/A | N/A |
| Healthy singleton births | N/A | N/A | N/A |
| Approach | Percentage of patients at this clinic | National percentage | ||
|---|---|---|---|---|
| Diagnoses | ||||
| Other, infertility | 22.0% | 29.8% | ||
| Male factor | 67.6% | 27.8% | ||
| Diminished ovarian reserve | 33.2% | 26.9% | ||
| Ovulatory dysfunction | 17.6% | 14.3% | ||
| Unknown factor | 0.0% | 10.6% | ||
| Tubal factor | 10.9% | 10.4% | ||
| Endometriosis | 5.3% | 6.4% | ||
| Recurrent pregnancy loss | 14.5% | 6.3% | ||
| Uterine factor | 7.9% | 5.8% | ||
| Other, non-infertility | 0.1% | 5.6% | ||
| Special procedures | ||||
| Banking cycles | 49.2% | 40.9% | ||
| Preimplantation Genetic Testing (PGT) | 17.8% | 16.3% | ||
| Fertility preservation | 10.2% | 8.7% | ||
| Surrogacy Services | 0.9% | 1.4% | ||